CorMedix
CRMD
6,04 €
Share price
-2.29%
Change (1 day)
22.91%
Change (1 year)
Categories
CorMedix (CRMD) - P/B ratio
P/B ratio as of April 2025 : 5.39
According to CorMedix's latest financial reports the company has a price-to-book ratio of 10.4957.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
CorMedix - P/B ratio (from 2010 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 5.88 | 100.27% |
| 2023-12-31 | 2.94 | -7.14% |
| 2022-12-31 | 3.16 | 14.66% |
| 2021-12-31 | 2.76 | -48.88% |
| 2020-12-31 | 5.40 | -31.68% |
| 2019-12-31 | 7.90 | -72.24% |
| 2018-12-31 | 28.5 | 508.54% |
| 2017-12-31 | 4.68 | 34.72% |
| 2016-12-31 | 3.47 | 61.75% |
| 2015-12-31 | 2.15 | -81.82% |
| 2014-12-31 | 11.8 | -330.57% |
| 2013-12-31 | -5.12 | -79.1% |
| 2012-12-31 | -24.5 | -1112.53% |
| 2011-12-31 | 2.42 | -15.45% |
| 2010-12-31 | 2.86 | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 2.39 | -55.75% | 🇺🇸 USA |
 | 0.5278 | -90.21% | 🇺🇸 USA |
 | 1.53 | -71.60% | 🇺🇸 USA |